Quantcast

Latest Attention-deficit hyperactivity disorder management Stories

2010-04-26 11:56:00

TITUSVILLE, N.J., April 26 /PRNewswire/ -- The Court of Appeals for the Federal Circuit has denied an appeal by McNeil Pediatrics, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., to overturn a 2009 decision by the U.S. District Court of Delaware that the patent for CONCERTA (methylphenidate HCl) Extended-Release Tablets CII is invalid and not infringed by Andrx Corporation. In December 2007, McNeil Pediatrics, which markets CONCERTA, and ALZA Corporation, the owner of the...

2010-04-15 13:02:50

Medication and behavioral interventions help children with Attention Deficit Hyperactivity Disorder (ADHD) better maintain attention and self control by normalizing activity in the same brain systems, according to researchers at The University of Nottingham. In a study, funded by the Wellcome Trust and published today in the journal Biological Psychiatry, researchers led by Chris Hollis, Professor of Child and Adolescent Psychiatry, in the School of Community Health Sciences, have shown that...

2010-03-31 11:28:49

Mount Sinai researchers have learned that meta-cognitive therapy (MCT), a method of skills teaching by use of cognitive-behavioral principles, yielded significantly greater improvements in symptoms of attention deficit hyperactivity disorder (ADHD) in adults than those that participate in supportive therapy. The study, titled "Meta-Cognitive Therapy," is now published in the American Journal of Psychiatry. Mary Solanto, Ph.D., Associate Professor in the Department of Psychiatry and Director...

2010-02-17 15:21:00

BRENTWOOD, Tenn., Feb. 17 /PRNewswire/ -- The Learning Lab of Brentwood will present a free seminar, Tips for Parenting ADHD Kids, on Thursday February 25 from 12:00-1:30 PM at the Community Services Building in Franklin. Dr. David Elkins, Clinical Psychologist and Supervising Psychologist of the Assessment Center at The Learning Lab of Brentwood, will lead the seminar. "Any parent with an ADHD child knows the daily challenges can often seem overwhelming," said Pat Elkins, Director of The...

2010-01-28 13:09:42

ADHD, or attention-deficit/hyperactivity disorder, is among the costliest of behavioral disorders. Its combination of inattention, impulsivity and hyperactivity leads to accidental injuries, school failure, substance abuse, antisocial behavior and more. Yet despite nearly a century of study, the disorder's roots remain mysterious. Much of modern ADHD research has focused on heritability of the condition, and indeed evidence suggests that genes may account for as much as 70 percent of...

2010-01-25 13:04:27

Children who are mixed-handed, or ambidextrous, are more likely to have mental health, language and scholastic problems in childhood than right- or left-handed children, according to a new study published today in the journal Pediatrics. The researchers behind the study, from Imperial College London and other European institutions, suggest that their findings may help teachers and health professionals to identify children who are particularly at risk of developing certain problems. Around one...

2009-12-21 08:00:00

PHILADELPHIA, Dec. 21 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the launch of its newest online Attention-Deficit/Hyperactivity Disorder (ADHD) resource, the ADHD Support Twitter(TM) page (http://twitter.com/adhdsupport), derived from the Shire award-winning online educational resource, ADHDSupport.com. The social networking service Twitter, estimated to reach approximately six million unique monthly visitors,...

2009-12-03 08:00:00

PHILADELPHIA, Dec. 3 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and...

2009-11-16 16:23:29

Primary objective of the study was to evaluate the safety of coadministration of INTUNIV with stimulants Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIVâ“ž¢ (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and...

2009-11-16 08:00:00

PHILADELPHIA, Nov. 16 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIV(TM) (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related